Sign In
Buy TRIB
$0.582
+0.0020 (+0.345%)
At Close: Jun 22, 2026
Trinity Biotech Earnings Calls
Mar 31, 2026
-$0.230 (25.81%)
| Release date | Jun 16, 2026 |
| EPS estimate | -$0.310 |
| EPS actual | -$0.230 |
| EPS Surprise | 25.81% |
| Revenue estimate | 10.682M |
| Revenue actual | - |
Dec 31, 2025
-$0.90 (-181.25%)
| Release date | Apr 30, 2026 |
| EPS estimate | -$0.320 |
| EPS actual | -$0.90 |
| EPS Surprise | -181.25% |
| Revenue estimate | 15M |
| Revenue actual | 11.064M |
| Revenue Surprise | -26.24% |
Sep 30, 2025
-$0.320 (37.25%)
| Release date | Dec 23, 2025 |
| EPS estimate | -$0.510 |
| EPS actual | -$0.320 |
| EPS Surprise | 37.25% |
| Revenue estimate | 10.5M |
| Revenue actual | 14.248M |
| Revenue Surprise | 35.70% |
Jun 30, 2025
| Release date | Jan 02, 2026 |
| EPS estimate | -$1.48 |
| EPS actual | - |
| Revenue estimate | 10.5M |
| Revenue actual | - |
Last 4 Quarters for Trinity Biotech
Below you can see how TRIB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2025
| Release date | Jan 02, 2026 |
| Price on release | $0.746 |
| EPS estimate | -$1.48 |
| EPS actual | - |
| Date | Price |
|---|---|
| Dec 26, 2025 | $1.00 |
| Dec 29, 2025 | $0.82 |
| Dec 30, 2025 | $0.82 |
| Dec 31, 2025 | $0.791 |
| Jan 02, 2026 | $0.746 |
| Jan 05, 2026 | $0.764 |
| Jan 06, 2026 | $0.765 |
| Jan 07, 2026 | $0.757 |
| Jan 08, 2026 | $0.742 |
| 4 days before | -25.38% |
| 4 days after | -0.536% |
| On release day | 2.33% |
| Change in period | -25.78% |
Sep 30, 2025
Beat
| Release date | Dec 23, 2025 |
| Price on release | $1.28 |
| EPS estimate | -$0.510 |
| EPS actual | -$0.320 |
| EPS surprise | 37.25% |
| Date | Price |
|---|---|
| Dec 17, 2025 | $0.93 |
| Dec 18, 2025 | $0.94 |
| Dec 19, 2025 | $0.90 |
| Dec 22, 2025 | $0.89 |
| Dec 23, 2025 | $1.28 |
| Dec 24, 2025 | $1.02 |
| Dec 26, 2025 | $1.00 |
| Dec 29, 2025 | $0.82 |
| Dec 30, 2025 | $0.82 |
| 4 days before | 38.23% |
| 4 days after | -35.94% |
| On release day | -20.31% |
| Change in period | -11.45% |
Dec 31, 2025
Missed
| Release date | Apr 30, 2026 |
| Price on release | $0.600 |
| EPS estimate | -$0.320 |
| EPS actual | -$0.90 |
| EPS surprise | -181.25% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $0.641 |
| Apr 27, 2026 | $0.645 |
| Apr 28, 2026 | $0.613 |
| Apr 29, 2026 | $0.600 |
| Apr 30, 2026 | $0.600 |
| May 01, 2026 | $0.608 |
| May 04, 2026 | $0.619 |
| May 05, 2026 | $0.602 |
| May 06, 2026 | $0.602 |
| 4 days before | -6.41% |
| 4 days after | 0.333% |
| On release day | 1.25% |
| Change in period | -6.10% |
Mar 31, 2026
Beat
| Release date | Jun 16, 2026 |
| Price on release | $0.570 |
| EPS estimate | -$0.310 |
| EPS actual | -$0.230 |
| EPS surprise | 25.81% |
| Date | Price |
|---|---|
| Jun 10, 2026 | $0.688 |
| Jun 11, 2026 | $0.675 |
| Jun 12, 2026 | $0.650 |
| Jun 15, 2026 | $0.677 |
| Jun 16, 2026 | $0.570 |
| Jun 17, 2026 | $0.580 |
| Jun 18, 2026 | $0.580 |
| Jun 22, 2026 | $0.582 |
| 4 days before | -17.09% |
| 4 days after | 2.11% |
| On release day | 1.74% |
| Change in period | -15.35% |
Trinity Biotech Earnings History
Earnings Calendar
FAQ
When is the earnings report for TRIB?
Trinity Biotech plc (TRIB) has scheduled its earnings report for Sep 03, 2026 after the markets close.
What is the TRIB price-to-earnings (P/E) ratio?
TRIB P/E ratio as of Jun 22, 2026 (TTM) is -0.287.
What is the TRIB EPS forecast?
The forecasted EPS (Earnings Per Share) for Trinity Biotech plc (TRIB) for the first fiscal quarter 2026 is -$0.260.
What are Trinity Biotech plc's retained earnings?
On its balance sheet, Trinity Biotech plc reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
